News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CytRx Laboratories, Inc. RNAi Subsidiary, RXi Pharmaceuticals, Names Vice President of Pharmaceutical Development


3/8/2007 12:15:50 PM

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation’s (NASDAQ:CYTR) majority-owned subsidiary, Worcester, Mass.-based RXi Pharmaceuticals Corporation (RXi), today announced that Pamela A. Pavco, Ph.D., has joined RXi as Vice President of Pharmaceutical Development.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES